Blockchain Registration Transaction Record

Onco-Innovations Targets Cancer with DNA Repair Inhibitors and AI

Onco-Innovations develops PNKP inhibitors and AI-driven precision oncology. Learn how this clinical-stage company targets DNA repair pathways to fight cancer.

Onco-Innovations Targets Cancer with DNA Repair Inhibitors and AI

This news matters because Onco-Innovations is advancing a novel class of cancer therapies that target DNA repair mechanisms, which could revolutionize treatment for solid tumors. For patients, this means potential new options when current therapies fail due to resistance. For investors, the company's dual approach combining drug development with AI could accelerate discovery and improve success rates, making it a compelling opportunity in the oncology space.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x374726c93224d9cd5452bcb01e18b923244ec1ddde2f15dea15c94c8c2c8bff3
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprinttallZb5a-21cc136888aa24ad27ff7ebe5ca4e8d1